Shay Capital »

Cytokinetics shares owned by Shay Capital

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Shay Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 82k 83.49

More positions owned by Shay Capital

Alibaba Group Hldg Sponsored Ads (BABA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Energy Transfer Com Ut Ltd Ptn Call Option (ET)
Purecycle Technologies (PCT)
Bgc Group Cl A (BGC)
NVIDIA Corporation (NVDA)
Tillys Cl A (TLYS)
Golar Lng SHS (GLNG)
International Game Technolog Shs Usd (IGT)
BJ's Restaurants (BJRI)
Baidu Spon Adr Rep A (BIDU)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Rekor Systems (REKR)
Turtle Beach Corp Com New (HEAR)

View all positions for Shay Capital

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics